Patrick J. Loehrer - Concepedia

Author

Patrick J. Loehrer

Indiana University – Purdue University Indianapolis ORCID

Also Known As

E F Smit, Loehrer P, Loehrer, Patrick, Loehrer, Patrick J, Loehrer, Patrick J., P J Loehrer, P Loehrer, P. J. Loehrer, P. Loehrer, P.J. Loehrer

542

Publications

26.1K

Citations

H-Index

169

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Indiana University School of Medicine Indiana University Health Palmetto Hematology Oncology Indiana University

About

Patrick J. Loehrer is an author at Indiana University – Purdue University Indianapolis specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	47	111	9.7K
2	Health Sciences	17	19	2.4K
3	Public Health	16	18	1.1K
4	Nursing	4	4	79
5	Allergy	1	1	12

Patrick J. Loehrer

205

Publications

22.7K

Citations

H-Index

Page 1

	Year	Citations
Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor Leonard B. Saltz, Neal J. Meropol, Patrick J. Loehrer, Journal of Clinical Oncology	2004	1.7K
Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide Stephen D. Williams, Robert Birch, Lawrence H. Einhorn, New England Journal of Medicine Cancer ResearchDisseminated Germ-cell TumorsSurgical OncologyMalignant DiseaseMedicine	1987	1.2K
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. Patrick J. Loehrer, Lawrence H. Einhorn, Paul Elson, Journal of Clinical Oncology	1992	984
Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer Mario A. Eisenberger, Brent A. Blumenstein, E. David Crawford, New England Journal of Medicine	1998	867
Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial Patrick J. Loehrer, Yang Feng, Higinia R. Cárdenes, Journal of Clinical Oncology	2011	817
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial Patrick J. Loehrer Yearbook of Oncology Hematological MalignancyLymphoid NeoplasiaOncologyChronic Lymphocytic LeukaemiaMedicine	2008	602
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. Scott Saxman, Kathleen J. Propert, Lawrence H. Einhorn, Journal of Clinical Oncology	1997	496
Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. Patrick J. Loehrer, R Gonin, Craig R. Nichols, Journal of Clinical Oncology	1998	399
Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. Lawrence H. Einhorn, Stephen D. Williams, Patrick J. Loehrer, Journal of Clinical Oncology Tumor BiologyUrologyOncologyOptimal DurationModerate Extent	1989	374
The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases Thomas M. Ulbright, Patrick J. Loehrer, Lawrence M. Roth, Cancer Surgical OncologyPathologyExtragonadal Germ Cell TumoursClinicopathologic StudyTotal Surgical Excision	1984	371

Page 1